We demonstrated previously that the activation of v-Abl protein tyrosine kinase (PTK) in IC.DP murine pre-mast cells resulted in suppression of apoptosis after withdrawal of interleukin 3 (IL-3), that protein kinase C (PKC) translocated to the nucleus 6 h after v-Abl PTK activation and that inhibition of PKC restored apoptosis after IL-3 deprivation in the presence of v-Abl PTK activity. Here we demonstrate that v-Abl PTK activation is followed by an approximately twofold increase in mRNA level of Bcl-X L by 6 h and a corresponding increase in Bcl-X L protein level by 24 h. Bcl-x L RNA and protein decreased in IL-3 deprived cells in the absence of v-Abl PTK activity. Exposure of cells with v-Abl PTK active to the PKC inhbitor calphostin C (125 ng/ml) prevented the increase in Bcl-x L protein and resulted in apoptosis. No changes in Bax or Bcl-2 protein level were noted after IL-3 withdrawal and/or activation of v-Abl PTK. Bak was barely detectable and Bad protein level decreased in cells undergoing apoptosis. The data suggest that suppression of apoptosis by v-Abl PTK in the absence of IL-3 is associated with PKC signalling and the upregulation of Bcl-x L in IC.DP cells.
It has been proposed that all cells undergo apoptosis by default if they do not receive survival signals (Ra, 1992) . Whether various survival stimuli (such as growth factors and interactions with appropriate extracellular matrices) share common downstream signalling elements that impinge upon, and suppress, the default apoptotic pathway is not known. One family of proteins known to play a central role in regulating the threshold at which spontaneous or damage induced apoptosis is engaged is the Bcl-2 family (Korsmeyer, 1992; Yang and Korsmeyer, 1996) comprised of suppressors of apoptosis including Bcl-2 (Vaux et al., 1988) and Bclx L (Boise et al., 1993) and the accelerators, Bax (Oltvai et al., 1993) , Bad (Yang et al., 1995) , Bak, (Farrow et al., 1995) and Bik (Boyd et al., 1995 ). An attractive model suggests that the ratio of homodimers to heterodimers within the family predicts cell fate (Reed, 1995, Yang and Korsmeyer, 1996) . Mechanisms regulating protein binding within the Bcl-2 family
are not yet clear. However, it has been shown Bcl-2 is phosphorylated on serine residues (Guan et al., 1996) and that serine/threonine phosphorylation of Bcl-2 can aect its ability to function as a suppressor of apoptosis (Haldar et al., 1989; May et al., 1994) . Moreover, serine phosphorylation of another member of the Bcl-2 family, Bad, aects its ability to bind to Bcl-2 or Bcl-X L (Zha et al., 1996) . Recent studies have also shown that interleukin 3 (IL-3) generated signals can lead to the upregulation or maintenance of Bcl-2 (Rinaudo et al., 1995) or Bcl-x L (Kinoshita et al., 1995) .
In order to study survival signalling pathways we have exploited a simple, readily manipulated cell system, the IC.DP murine pre-mast cell line which depends upon IL-3 to survive and proliferate (Kipreos and Wang, 1988) . We previously demonstrated that activation of a temperature sensitive mutant of v-Abl protein tyrosine kinase (v-Abl PTK) resulted in the suppresssion of apoptosis after withdrawal of IL-3 (Evans et al., , 1995 or exposure to several anticancer agents (Chapman et al., 1994 (Chapman et al., , 1995 . v-Abl PTK is active at 328C and inactive at 398C. In the absence of IL-3 with v-Abl PTK active IC.DP cells survive but do not proliferate (unlike the stimulus provided by IL-3) thus allowing survival signalling to be studied speci®cally.
Activation of v-Abl PTK in IC.DP cells (used here) resulted in autophosphorylation which was detectable at 2 h after temperature switch and was maximal by 4 h. Between 6 and 18 h there were increases in phosphocholine, inositol 1, 4, 5 trisphosphate and diacylglycerol, the physiological activator of protein kinase C . These signalling events were reversible with reversed temperature switch to deactivate v-Abl PTK . We have shown that v-Abl PTK activation results in translocation of PKC bII to the nucleus, that nuclear PKC activity is increased and that inhibition of PKC by calphostin C restores an apoptotic response to IL-3 deprivation in the presence of v-Abl PTK activity (Evans et al., 1995) . v-Abl PTK activation in IC.DP cells also results in the phosphorylation of SHC and the activation of Ras-GAP although there was no evidence for the subsequent activation of ERK1 or ERK2 . In addition, v-Abl PTK activity has pronounced aects on glucose transport (Kan et al., 1994) and intracellular pH (Owen-Lynch et al., 1993; Chen et al., 1997) . Thus v-Abl PTK exerts multiple eects in IC.DP cells although it is not yet clear which of the above are absolutely required for the suppression of apoptosis. Given the ability of IL-3 to aect Bcl-2 and Bcl-x L levels in certain haemopoietic cell types, we asked whether activation of v-Abl PTK could also suppress apoptosis via aects on Bcl-2 family members. Moreover because v-Abl PTK activates PKC and there is increasing evidence that PKC can play a role in survival signalling, including that elicited by IL-3 (Rinaudo et al., 1995 , reviewed by Dive et al., 1992a , we also asked whether PKC activity was an intermediate step in the signal transduction pathway between v-Abl PTK and the Bcl-2 family.
We used a¯ow cytometric approach (Dive et al., 1992b) to con®rm our previous observations that v-Abl PTK suppresses apoptosis upon IL-3 deprivation. This assay exploits alterations in the cellular accumulation and DNA binding of the¯uorochrome Hoechst 33342 and typically detects apoptotic cells at an earlier stage than would be detected using assays based on the uptake of trypan blue or propidium iodide. The kinetics of apoptosis in these cell lines following IL-3 removal have been previously described in detail . Figure 1 demonstrates maintenance of IC.DP cell viability for up to 48 h after IL-3 withdrawal in the presence of active v-Abl PTK. Corresponding data for the parental IC2.9 cells (which do not express v-Abl PTK) are included to control for temperature eects. At 6 h, the timepoint when changes in Bcl-x L were ®rst noted, there were only basal levels of apoptosis (5 ± 10%) in IC.DP and IC2.9 cells at either temperature and no DNA laddering was detectable (data not shown, see Evans et al., 1993) . Next we examined the levels of Bcl-2 and Bax proteins in the presence and absence of v-Abl PTK activation after withdrawal of IL-3. There were no changes in the level of Bcl-2 (Figure 2a) . Similarly there were no changes in Bax protein levels over 24 h (Figure 2b ). We did not extend this analysis because of the increasing percentage of apoptotic cells in IC2.9 cells and IC.DP cells at 398C beyond 24 h. We also examined the protein levels of the apoptosis promoters, Bak and Bad. Bak was barely detectable at any time point in either cell line (data not shown) and Bad levels were decreased in the absence of v-Abl PTK activity when a proportion of the cells began to undergo apoptosis ( Figure 2c ).
In contrast, 24 h after the activation of v-Abl PTK there was a reproducible increase in the protein levels of Bcl-x L compared to that seen at 0 h ( Figure 3a) . Figure 1 Suppression of IL-3 withdrawal induced apoptosis by activation of v-Abl PTK. IC.DP and IC2.9 cells were cultured, deprived of IL-3 and in some experiments exposed to calphostin C as previously described (Evans et al., , 1995 . Apoptosis was measured by¯ow cytometry using the assay described by Dive et al. Densitometric analysis showed that Bcl-x L protein levels were unchanged at 6 h but increased 2.34-fold by 24 h (+0.12, n=6, Table 1 ). In the absence of IL-3 and v-Abl PTK activity there was a reduction in Bcl-x L protein level which coincided with the onset of apoptosis in both cel types. v-Abl PTK activation also resulted in increased Bcl-x L protein levels in the presence of IL-3 (data not shown). In the absence of vAbl PTK activity, IL-3 prevented a decrease in Bcl-x L (data not shown). In order to con®rm our observation that Bcl-x L was upregulated after activation of v-Abl PTK and to determine the level of heterogeneity within the cell samples, we examined Bcl-x associated immuno¯uorescence by¯ow cytometry (Figure 3b ). Cells already undergoing apoptosis were excluded from the analysis based upon their light scatter pro®le (decreased forward light scatter and increased orthogonal light scatter) and these cells did not exhibit Bcl-x associated immuno¯uorescence. The¯ow cytometric data were consistent with those obtained by Western blotting showing a 2.6+0.6-fold increase (n=3) in Bclx associated immuno¯uorescence in the total cell population 24 h after v-Abl PTK activation compared to that at 0 h. A decrease in Bcl-x¯uorescence was observed in the parental IC2.9 cells and the IC.DP subline at the non-permissive temperature for v-Abl PTK activity. Although there were no distinct cell subpopulations based on Bcl-x staining there was a general shift in the whole population at 24 h with vAbl PTK active. This shift resulted in 25% of the IC.DP cells with active v-Abl PTK exhibitinḡ uorescence above that of the median¯uorescence at 0 h. The¯ow cytometric assay does not distinguish between the splice variant forms of Bcl-x but given our inability to detect Bcl-x S by Western blotting (see Figure 3a) , it is reasonable to assume that the increase in¯uorescence seen with v-Abl PTK active is due to increased Bcl-x L levels.
Northern blot analysis demonstrated that the observed increase in Bcl-x L protein level was re¯ected Bcl-x associated immuno¯uorescence detected by¯ow cytometry. 1.5610 6 cells were ®xed in 2% paraformaldehyde at room temperature for 10 min, washed in stain buer (5% normal goat serum, 0.02% sodium azide in PBS) and then stored at 48C. 5610 5 cells per sample were then incubated with 0.3% saponin in buer containing either (a) a 1 : 7 dilution of a mouse IgG2b antibcl-X monoclonal antibody, (b) a 1 : 7 dilution of an IgG2b isotype speci®c mouse antibody raised against Aspergillus niger glucose oxidase (irrelevant antibody, DAKO), or (c) no primary antibody, for 30 min at 48C. All incubations were washed twice in buer containing 0.03% saponin and pelleted at 48C. The pellet was then resuspended in 1 : 25 dilution of FITC-conjugated rabbit anti-mouse F(ab') 2 fragment (DAKO, Denmark) in stain buer containing 0.3% saponin and incubated for 30 min at 48C. The cells were washed as above and then resuspended in 0.5% PFA in stain buer prior to¯ow cytometric analysis of forward and orthogonal light scatter and green¯uorescence (530+30 nm) for 10 000 cells per sample using the 488 nm line of the Enterprise laser set to excite at 250 mW. The fold increase of Bcl-x associated¯uorescence at 24 h is normalised to the appropriate sample at the 0 h. Data shown are the mean value +s.e. of three repeat experiments. (c) Bcl-x mRNA level detected by Northern blot using 20 mg of total RNA. Total RNA was extracted from IC. DP and IC2.9 cells and Northern blotting was performed according to Maniatis et al. (1989) . Bcl-X probe from pcDNA3 plasmid was a generous gift from Sabina Cosulich, School of Biological Sciences, Manchester University. A 2.7 kb band is expected for Bcl-X (Boise et al., 1993) . Equal loading of RNA was assessed by comparison of GAPDH RNA levels. The GAPDH probe was a kind gift from Andrew Pierce, Dept Biochemistry, University of Manchester Institute of Science and Technology). Data are representative of four separate experiments Densitometric analysis was performed using a Bio-rad GS 700 densitometer and the Bio-Rad software Molecular Analyst. In order to quantify results by densitometry, the linearity of ECL detection was con®rmed by calibration using a range of protein concentrations encompassing that used in the experiments. Data are displayed as fold increase normalized to the corresponding sample at the 0 h time point. Data are the average of three repeat experiments at the level of RNA. An increase in Bcl-x mRNA was observed 6 h after activation of v-Abl PTK and although it declined thereafter, it remained above basal levels at 24 h (Figure 3c ). In two repeat experiments, the increase noted at 6 h was of the order of 1.8 ± 2.0-fold (Table 2) . No increase in Bcl-x mRNA was seen at 328C in IC2.9 cells at any time point and in accordance with the results obtained for Bcl-x L protein, the message levels decreased over time in the absence of v-Abl PTK activity prior to the appearance of apoptotic cells (Figure 1, Figure 3c , Table 2 ). IL-3 stimulation of IC.DP cells, in the absence of v-Abl PTK activity resulted in a detectable increase in Bcl-x mRNA over 6 ± 24 h but to a lesser degree than observed for v-Abl activation (data not shown).
The dependence upon protein synthesis for v-Abl PTK mediated suppression of apoptosis was investigated using cycloheximide. Exposure of IC.DP cells with v-Abl PTK active to 10 mM cycloheximide prevented the upregulation of Bcl-x L protein at 24 h (data not shown) and resulted in apoptosis (Table 3) .
Given our previous observations that v-Abl PTK activation is followed by the nuclear translocation of PKC and an increase in PKC activity within and around the nucleus (Evans et al., 1995) , we next examined the eects of the PKC inhibitor calphostin C on v-Abl PTK mediated upregulation of Bcl-x L protein. Figure 4 shows that IC.DP cells with v-Abl PTK active which have been exposed to 125 ng/ml caphostin C for 24 ± 48 h no longer expressed raised levels of Bcl-x L ; indeed the levels were decreased below control. These cells died by apoptosis between 24 and 72 h. We demonstrated previously that at 125 ng/ml calphostin C had no detectable eects on tyrosine phosphorylation (Evans et al., 1995) . At 50 ng/ml calphostin C aected neither the upregulation of Bcl-x L at 24 h nor the suppression of apoptosis by v-Abl PTK.
Activated forms of the Abl protein tyrosine kinase can potently suppress apoptosis in various haemopoietic cells lines induced by cytokine deprivation, exposure to DNA damaging agents and death signalling through the Apo-1/Fas receptor McGahon et al., 1995; Chapman et al., 1995; Bedi et al., 1995) . Here we sought to determine the molecular mechanisms involved in the suppression of apoptosis by v-Abl protein tyrosine kinase in the IC.DP cell line. The vAbl oncogene encodes a fusion protein of viral Gag sequences and the C terminal portion of the protooncogene c-abl (Wang and Baltimore, 1983; Chung and Wong, 1995; Konopka and Witte, 1985) . Both v-Abl and Bcr/Abl, the hallmark of chronic myeloid leukaemia, are constitutively activated and are predominantly cytoplasmic tyrosine kinases with the ability to transform haemopoietic cells.
The Bcl-2 family of proteins are involved in the regulation of the threshold at which cells can undergo spontaneous or stress induced apoptosis (Yang and Korsmeyer, 1996) . In IC.DP murine pre-mast cells deprived of IL-3 v-Abl PTK had no eect on the protein levels of Bcl-2 but upregulated Bcl-x L (Figures 2 ± 3, Tables 1 and 2 ). The increased levels of Bcl-x L protein are mirrored by earlier changes at the message level (Figure 3c ). The ratio of heterodimers to homodimers within the Bcl-2 family is proposed to dictate cell fate (Hanada et al., 1995) . Bcl-x L binds to itself and to the apoptosis accelerating family members Bax, Bak and Bad (Yang and Korsmeyer, 1996) . We were barely able to detect Bak in IC.DP cells and there was no change in Bax protein levels after v-Abl PTK activation (Figure 2b ). The levels of Bad remained unchanged in surviving cells with v-Abl active, but surprisingly, were decreased in the absence of v-Abl PTK and IL-3 when cells underwent apoptosis. Taken together our data suggest that the upregulation of Bclx L by v-Abl PTK may result in a scenario whereby BclxL heterodimers with Bax and Bad homodimers conducive to cell survival are in excess of Bax and Bad homodimers conducive to apoptosis. The eects of v-Abl PTK on Bcl-2 family members and the regulation of apoptosis have been studied recently in HL60 human promyeocytic leukaemia cells exposed to DNA damaging agents (DR Green, personal communication). Here, v-Abl PTK activity resulted in a similar shift in the ratio of Bcl-x L to Bax. However, ) 3 2 8 C 3 9 8 C 3 2 8 C 3 9 8 C Densitometric analysis was performed using a Bio-rad GS 700 densitometer and the Bio-Rad software Molecular Analyst. Data are displayed as fold increase normalized to the corresponding sample at the 0 h time point. Data are from two repeat experiments The percentage apoptosis was measured by examination of nuclear morphology of cells were stained with 10 mg/ml Hoechst 333342 and examined by¯uorescence microscopy. Data presented are the mean value of three repeat experiments Control +50ng/ml +125ng/ml Control +50ng/ml +125ng/ml Control +50ng/ml +125ng/ml -Bcl-x L 30 kD0h 6h 24h 48h Figure 4 Eect of calphostin C (at 50 ng/ml and 125 ng/ml) on v-Abl PTK mediated upregulation of Bcl-x L . Western blotting was performed as described by Chen et al. (1997) (Rinaudo et al., 1995; Sanchez-Garcia and GruÈ tz, 1995; Kinoshita et al., 1995) . Firstly, Rinaudo and colleagues (1995) demonstrated that IL-3 plays a role in maintaining Bcl-2 transcription via activation of PKC in the erythroleukaemia cell line TF-1 and that withdrawal of IL-3 resulted in a downregulation of bcl-2 prior to the onset of apoptosis. Secondly, IL-3 has also been shown to maintain the levels of both Bcl-2 and Bcl-X L in 32D multipotent myeloid progenitor cells (Kinoshita et al., 1995) . Thirdly, Bcr/Abl expression resulted in the upregulation of Bcl-2 at the RNA and protein level in BA/F3 cells (Sanchez-Garcia and GruÈ tz, 1995) . Thus, depending of the cell context, the oncogenic Abl PTKs and IL-3 can modulate the levels of dierent Bcl-2 family members with the net result of suppression of apoptosis.
How might these changes in Bcl-2 family members brought about by IL-3 and the oncogenic Abl PTKs occur? There have been many studies of the signal transduction pathways activated by IL-3, Bcr/Abl and v-Abl. There are both similarities and clear dierences in the signals elicited by the v-Abl and Bcr/Abl tyrosine kinases and in those stimulated by IL-3 (Kaborowski et al., 1994; Cortez et al., 1995; Shuai et al., 1996; Daniel et al., 1995) . Moreover, dramatic dierences in signalling pathways engaged by these oncogenic tyrosine kinases exist between cell types, notably between haemopoeitic cells and ®broblasts (Sawyers et al., 1994) . Clearly caution is required when attempting to formulate a universal theory for survival signalling from IL-3 and Abl TKs. This said, Cortez and colleagues demonstrated activation of Bcr/Abl PTK resulted in the association of SHC and GRB-2 and the activation of p21 ras the latter being necessary for the suppression of apoptosis in 32D cells (Cortez et al., 1995) . In the IC.DP cell line used for our study, vAbl PTK activity led to the phosphorylation of SHC, the Ras-GTPase activating protein although in contrast to IL-3 signalling, there was minimal activation of ERK1 or ERK2 . Both IL-3 and v-Abl stimulated the activity of Raf in the IL-3 dependent myeloid cell line FDC-P1 (Carroll et al., 1990) . Taken together results suggest that activation of Raf may be required for suppression of apoptosis by IL-3, v-Abl and Bcr/Abl although signalling through to ERKs is not. The direction of p21 ras generated signals towards cell survival and proliferation or towards apoptosis has been proposed to be in¯uenced by both the activity of protein kinase C and the expression of Bcl-2 (Chen and Faller, 1995) . These investigators showed that constitutively activated Ras would drive apoptosis in Jurkat T lymphoblastoid cells if PKC was inhibited or downregulated. This apoptosis was overcome by overexpressed Bcl-2. Inhibition and/or downregulation of PKC has been shown previously in many studies to induce apoptosis in many cell types although many of these studies suer from the use of compounds which inhibit other kinases in addition to PKC (reviewed by Dive et al., 1992a) . More recently activation of PKC has been shown to suppress ceramide induced apoptosis (Cuvillier et al., 1996) , and from our own studies appears to be important for v-Abl mediated suppression of apoptosis induced by cytokine deprivation and exposure to anticancer drugs (Evans et al., 1995; Chapman et al., 1995) . The activity of PKC may either lead to regulation of Bcl-2 and Bclx L via eects on transcription, and/or may aect their function via posttranslational modi®cation. With respect to the latter possibility, the phosphorylation of Bcl-2 by PKC has been previously proposed following IL-3 stimulation of murine myeloid FDC-P1/ER cells (May et al., 1994) and in Jurkat cells the phosphorylation status of Bcl-2 is modulated by inhibition of PKC (Chen and Faller, 1995) . The picture is complex however given the report of a minimum of at least three serine threonine phosphorylation sites on Bcl-2 (Guan et al., 1996) and it is not yet clear whether phosphorylation at dierent sites or combinations of sites results in enhancement or abrogation of the survival function of Bcl-2. Analysis of the amino acid sequence of Bcl-xL would suggest the existence of several putative PKC phosphorylation sites. The nuclear translocation of PKC bII in IC.DP cells with active v-Abl PTK places it in a con®rmed location of Bcl-x L , i.e. the nuclear periphery, and studies are underway to investigate whether this is of relevance, whether PKC directly phosphorylates Bcl-x L and/or whether PKC activity in the nucleus results in changes in transcription. In summary our previous data show that v-Abl PTK can activate PKC and taken together the signalling data summarised above are consistent with a model whereby oncogenic Abl tyrosine kinases may activate both p21 ras and PKC, as well as altering the levels of Bcl-2 and/or Bcl-x L to suppress apoptosis.
